Breast Cancer
Breast Cancer Immunotherapy Response Markers Emerge From Single-Cell Sequencing Study
Researchers identified several pre-treatment markers that correlated with T-cell expansion and could be predictive of response to a PD1 inhibitor.
For patients with ductal carcinoma in situ, stromal PDGFRb expression could predict radiation benefit, and potentially lead to effective combination therapies.
GE Healthcare Acquiring Zionexa for Access to Breast Cancer PET Imaging Agent
GE intends to scale access to the PET imaging agent so at least 75 percent of metastatic breast cancer patients in the US have access to it by 2023.
Outcomes4Me Raises $12M in Series A Financing
The firm will use the funds to expand the reach of its AI-powered patient education platform and to collect data for longitudinal real-world datasets.
Genetic Testing Challenges in Oncology: BRCA1-Positive Patient Told Paternal Cancer Risk Unimportant
A case series in partnership with My Gene Counsel to highlight the challenges genetics professionals and oncologists are grappling with as genetic testing is increasingly used in patient care.